Short answer
Compass Therapeutics, Inc. (CMPX) filed an 8-K current report with the SEC on June 23, 2026 reporting Item 5.03 (Amendments to Articles of Incorporation or Bylaws). Board-adopted bylaws effective June 22, 2026.
Compass Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.03 · Amendments to Articles of Incorporation or Bylaws
- Board-adopted bylaws effective June 22, 2026
- Securities Act claims assigned to exclusive federal jurisdiction in Delaware or Massachusetts
- Forum-selection provision may limit shareholder litigation venue flexibility
- Full Second Amended and Restated Bylaws filed as Exhibit 3.1
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Compass Therapeutics, Inc. 8-K filings
Get the next CMPX 8-K as it lands
Follow CMPX for push alerts, or ask the research agent what this filing means.